|
|
Blood, 15 April 2007, Vol. 109, No. 8, pp. 3316-3324.
Prepublished online as a Blood First Edition Paper on December 14, 2006; DOI 10.1182/blood-2006-07-038059.
Previous Article | Next Article 
Submitted July 27, 2006
Accepted December 7, 2006
The Pten/PI3K pathway governs the homeostasis of V 14 iNKT cells
Hiroyuki Kishimoto, Toshiaki Ohteki, Nobuyuki Yajima, Koichi Kawahara, Miyuki Natsui, Satoru Kawarasaki, Koichi Hamada, Yasuo Horie, Yoshiaki Kubo, Seiji Arase, Masaru Taniguchi, Bart Vanhaesebroeck, Tak Wah Mak, Toru Nakano, Shigeo Koyasu, Takehiko Sasaki, and Akira Suzuki*
Department of Molecular Biology, Akita University School of Medicine, Akita, Japan
Department of Immunology, Akita University School of Medicine, Akita, Japan
Department of Gastroenterology, Akita University School of Medicine, Akita, Japan
Department of Dermatology, Institute of Health Bioscience, Graduate School of Medicine, The University of Tokushima, Tokushima, Japan
RIKEN Research Center for Allergy and Immunology, Kanagawa, Japan
Ludwig Institute for Cancer Research, London, United Kingdom
The Campbell Family Institute of Breast Cancer Research, Toronto, Canada
Department of Pathology, Medical School and Graduate School of Frontier Biosciences, Osaka University, Suita, Japan
Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan
Department of Microbiology, Akita University School of Medicine, Akita, Japan
* Corresponding author; email: suzuki{at}med.akita-u.ac.jp.
The tumor suppressor PTEN is mutated in many human cancers. We previously used the Cre-loxP system to generate mice (LckCrePten mice) with a Pten mutation in T lineage cells. Here we describe the phenotype of Pten-deficient V 14iNKT cells. A failure in the development of V 14iNKT cells occurs in the LckCrePten thymus between Stage2 (CD44highNK1.1-) and Stage3 (CD44highNK1.1+), resulting in decreased numbers of peripheral V 14iNKT cells. In vitro, Pten-deficient V 14iNKT cells show reduced proliferation and cytokine secretion in response to GalCer stimulation but enhanced inhibitory Ly-49 receptor expression. Following interaction with DCs loaded with GalCer, Pten-deficient V 14iNKT cells demonstrate activation of PI3K. Indeed, the effects require intact function of the PI3K subunits p110 and p110 . In vivo, LckCrePten mice display reduced serum IFN after GalCer administration. Importantly, V 14iNKT cell-mediated protection against metastasis of melanoma cells to the lung was impaired in the absence of Pten. Thus, the Pten/PI3K pathway is indispensable for the homeostasis and anti-tumor surveillance function of V 14iNKT cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Guo, A. Samarakoon, B. Vanhaesebroeck, and S. Malarkannan
The p110{delta} of PI3K plays a critical role in NK cell terminal maturation and cytokine/chemokine generation
J. Exp. Med.,
September 29, 2008;
205(10):
2419 - 2435.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Johnson, S. Tsutsui, and F. R. Jirik
Antigen-Induced Pten Gene Deletion in T Cells Exacerbates Neuropathology in Experimental Autoimmune Encephalomyelitis
Am. J. Pathol.,
April 1, 2008;
172(4):
980 - 992.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|